Author

Hubert Schrezenmeier

Primary ORCID profile (0000-0003-1222-6659 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Hubert SchrezenmeieriD3 papers · Universität Ulm

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexander Hoellein· 1 shared Alexej Knaus· 1 shared Britta Hoechsmann· 1 shared Jun-ichi Nishimura· 1 shared Makiko Osato· 1 shared Markus Anliker· 1 shared Marten Jaeger· 1 shared Michi KawamotoiD· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexander Hoellein

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintMay 13, 2019

Complement- and inflammasome-mediated autoinflammation-paroxysmal nocturnal hemoglobinuria

Britta Hoechsmann, Yoshiko Murakami, Makiko Osato…·Taroh Kinoshita

This study identifies AIF-PNH as a disease caused by germline and somatic mutations in PIGT, leading to complement activation and inflammasome-mediated IL-1β secretion, which is treatable with eculizumab.

DOI 10.1101/635573

humanproteomics

𝕏 PostBluesky